{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:52:30Z","timestamp":1785855150201,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05203-w","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:42:43Z","timestamp":1780299763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The RNA-binding protein RBFOX2 suppresses colorectal cancer proliferation and metastasis by reducing FUBP1 mRNA stability to induce mitochondrial dysfunction and ferroptosis"],"prefix":"10.1007","volume":"17","author":[{"given":"WenDong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuangMing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuoLong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinTuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"issue":"1","key":"5203_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5203_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20120240","volume":"124","author":"X Liu","year":"2013","unstructured":"Liu X, Zhang H, Lai L, Wang X, Loera S, Xue L, et al. Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers. Clin Sci (Lond). 2013;124(9):567\u201378.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"5203_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1053\/j.seminoncol.2011.05.009","volume":"38","author":"JM Davies","year":"2011","unstructured":"Davies JM, Goldberg RM. Treatment of metastatic colorectal cancer. Semin Oncol. 2011;38(4):552\u201360.","journal-title":"Semin Oncol"},{"issue":"Pt 2","key":"5203_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.semcancer.2022.03.025","volume":"86","author":"W Li","year":"2022","unstructured":"Li W, Deng X, Chen J. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin Cancer Biol. 2022;86(Pt 2):664\u201377.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5203_CR5","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1038\/s41467-024-48046-1","volume":"15","author":"M Bak","year":"2024","unstructured":"Bak M, van Nimwegen E, Kouzel IU, Gur T, Schmidt R, Zavolan M, et al. MAPP unravels frequent co-regulation of splicing and polyadenylation by RNA-binding proteins and their dysregulation in cancer. Nat Commun. 2024;15(1):4110.","journal-title":"Nat Commun"},{"issue":"1","key":"5203_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.celrep.2018.06.017","volume":"24","author":"RK Singh","year":"2018","unstructured":"Singh RK, Kolonin AM, Fiorotto ML, Cooper TA. Rbfox-Splicing Factors Maintain Skeletal Muscle Mass by Regulating Calpain3 and Proteostasis. Cell Rep. 2018;24(1):197\u2013208.","journal-title":"Cell Rep"},{"issue":"6","key":"5203_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nsmb.1608","volume":"16","author":"JP Venables","year":"2009","unstructured":"Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, et al. Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol. 2009;16(6):670\u20136.","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"5203_CR8","doi-asserted-by":"publisher","first-page":"e1002218","DOI":"10.1371\/journal.pgen.1002218","volume":"7","author":"IM Shapiro","year":"2011","unstructured":"Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 2011;7(8):e1002218.","journal-title":"PLoS Genet"},{"issue":"9","key":"5203_CR9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/onc.2013.50","volume":"33","author":"C Braeutigam","year":"2014","unstructured":"Braeutigam C, Rago L, Rolke A, Waldmeier L, Christofori G, Winter J. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion. Oncogene. 2014;33(9):1082\u201392.","journal-title":"Oncogene"},{"issue":"7959","key":"5203_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41586-023-05820-3","volume":"617","author":"A Jbara","year":"2023","unstructured":"Jbara A, Lin KT, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, et al. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Nature. 2023;617(7959):147\u201353.","journal-title":"Nature"},{"issue":"9","key":"5203_CR11","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41556-023-01213-w","volume":"25","author":"X Dou","year":"2023","unstructured":"Dou X, Xiao Y, Shen C, Wang K, Wu T, Liu C, et al. RBFOX2 recognizes N(6)-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. Nat Cell Biol. 2023;25(9):1359\u201368.","journal-title":"Nat Cell Biol"},{"issue":"16","key":"5203_CR12","doi-asserted-by":"publisher","first-page":"e2004852","DOI":"10.1002\/advs.202004852","volume":"8","author":"CL Luo","year":"2021","unstructured":"Luo CL, Xu XC, Liu CJ, He S, Chen JR, Feng YC, et al. RBFOX2\/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis. Adv Sci (Weinh). 2021;8(16):e2004852.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"5203_CR13","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/ijc.33758","volume":"149","author":"Y Mochizuki","year":"2021","unstructured":"Mochizuki Y, Funayama R, Shirota M, Kikukawa Y, Ohira M, Karasawa H, et al. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer. Int J Cancer. 2021;149(10):1787\u2013800.","journal-title":"Int J Cancer"},{"issue":"24","key":"5203_CR14","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1038\/onc.2012.350","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang J, Chen QM. Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene. 2013;32(24):2907\u201316.","journal-title":"Oncogene"},{"issue":"2","key":"5203_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1724600820912252","volume":"35","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu J, Geng N, Feng C. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma. Int J Biol Markers. 2020;35(2):56\u201365.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"5203_CR16","doi-asserted-by":"publisher","first-page":"e0169852","DOI":"10.1371\/journal.pone.0169852","volume":"12","author":"J Duan","year":"2017","unstructured":"Duan J, Bao X, Ma X, Zhang Y, Ni D, Wang H, et al. Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma. PLoS ONE. 2017;12(1):e0169852.","journal-title":"PLoS ONE"},{"issue":"1","key":"5203_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13046-019-1414-6","volume":"38","author":"P Jiang","year":"2019","unstructured":"Jiang P, Huang M, Qi W, Wang F, Yang T, Gao T, et al. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma. J Exp Clin Cancer Res. 2019;38(1):400.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"5203_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4149\/neo_2014_065","volume":"61","author":"MY Jia","year":"2014","unstructured":"Jia MY, Wang YJ. Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue. Neoplasma. 2014;61(5):533\u201340.","journal-title":"Neoplasma"},{"issue":"12","key":"5203_CR19","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1002\/1878-0261.13064","volume":"15","author":"H Yin","year":"2021","unstructured":"Yin H, Gao T, Xie J, Huang Z, Zhang X, Yang F, et al. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt\/\u03b2-catenin signaling. Mol Oncol. 2021;15(12):3490\u2013512.","journal-title":"Mol Oncol"},{"issue":"5","key":"5203_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"22","key":"5203_CR21","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s00018-020-03536-5","volume":"77","author":"A Kirtonia","year":"2020","unstructured":"Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 2020;77(22):4459\u201383.","journal-title":"Cell Mol Life Sci"},{"key":"5203_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","volume":"9","author":"X Sui","year":"2018","unstructured":"Sui X, Zhang R, Liu S, Duan T, Zhai L, Zhang M, et al. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer. Front Pharmacol. 2018;9:1371.","journal-title":"Front Pharmacol"},{"key":"5203_CR23","doi-asserted-by":"publisher","first-page":"105450","DOI":"10.1016\/j.ejps.2020.105450","volume":"152","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci. 2020;152:105450.","journal-title":"Eur J Pharm Sci"},{"key":"5203_CR24","doi-asserted-by":"publisher","first-page":"102493","DOI":"10.1016\/j.redox.2022.102493","volume":"57","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen S, Wei S, Cheng S, Shi R, Zhao R, et al. CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biol. 2022;57:102493.","journal-title":"Redox Biol"},{"key":"5203_CR25","doi-asserted-by":"publisher","first-page":"1302134","DOI":"10.3389\/fphar.2024.1302134","volume":"15","author":"F Huang","year":"2024","unstructured":"Huang F, Jin L, Zhang X, Wang M, Zhou C. Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors. Front Pharmacol. 2024;15:1302134.","journal-title":"Front Pharmacol"},{"issue":"10","key":"5203_CR26","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1093\/nar\/gkv210","volume":"43","author":"M Danan-Gotthold","year":"2015","unstructured":"Danan-Gotthold M, Golan-Gerstl R, Eisenberg E, Meir K, Karni R, Levanon EY. Identification of recurrent regulated alternative splicing events across human solid tumors. Nucleic Acids Res. 2015;43(10):5130\u201344.","journal-title":"Nucleic Acids Res"},{"key":"5203_CR27","doi-asserted-by":"publisher","first-page":"796451","DOI":"10.3389\/fcell.2021.796451","volume":"9","author":"X Ou","year":"2022","unstructured":"Ou X, Zhou X, Li J, Ye J, Liu H, Fang D, et al. p53-Induced LINC00893 Regulates RBFOX2 Stability to Suppress Gastric Cancer Progression. Front Cell Dev Biol. 2022;9:796451.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5203_CR28","doi-asserted-by":"publisher","first-page":"102041","DOI":"10.1016\/j.jormas.2024.102041","volume":"126","author":"P Arumugam","year":"2025","unstructured":"Arumugam P, M SM, Jayaseelan VP. A novel m6A reader RBFOX2 expression is increased in oral squamous cell carcinoma and promotes tumorigenesis. J Stomatol Oral Maxillofac Surg. 2025;126(1):102041.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"10","key":"5203_CR29","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.62347\/BNPO2363","volume":"14","author":"S Liao","year":"2024","unstructured":"Liao S, Zhou Z, Jiao Y, Chen S, Bao Y, Cao J, et al. RBFOX2 as a regulatory linchpin in cancer: insights from a comprehensive review of its roles in tumorigenesis. Am J Cancer Res. 2024;14(10):5045\u201360.","journal-title":"Am J Cancer Res"},{"key":"5203_CR30","doi-asserted-by":"crossref","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci. 2022;24(1).","DOI":"10.3390\/ijms24010449"},{"issue":"10\u201312","key":"5203_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/ars.2022.0173","volume":"39","author":"P Je\u017eek","year":"2023","unstructured":"Je\u017eek P, Jab\u016frek M, Holendov\u00e1 B, Engstov\u00e1 H, Dlaskov\u00e1 A. Mitochondrial Cristae Morphology Reflecting Metabolism, Superoxide Formation, Redox Homeostasis, and Pathology. Antioxid Redox Signal. 2023;39(10\u201312):635\u201383.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"5203_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.7150\/ijbs.80775","volume":"19","author":"Q Lin","year":"2023","unstructured":"Lin Q, Li S, Jin H, Cai H, Zhu X, Yang Y, et al. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS\/HO-1\/GPX4 axis. Int J Biol Sci. 2023;19(4):1192\u2013210.","journal-title":"Int J Biol Sci"},{"issue":"Pt 2","key":"5203_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.semcancer.2022.03.018","volume":"86","author":"S Wang","year":"2022","unstructured":"Wang S, Sun Z, Lei Z, Zhang HT. RNA-binding proteins and cancer metastasis. Semin Cancer Biol. 2022;86(Pt 2):748\u201368.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"5203_CR34","doi-asserted-by":"publisher","first-page":"2005420","DOI":"10.1080\/21688370.2021.2005420","volume":"10","author":"SN Rubtsova","year":"2022","unstructured":"Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers. 2022;10(4):2005420.","journal-title":"Tissue Barriers"},{"issue":"8","key":"5203_CR35","doi-asserted-by":"publisher","first-page":"C511","DOI":"10.1152\/ajpcell.00117.2015","volume":"309","author":"L Novellasdemunt","year":"2015","unstructured":"Novellasdemunt L, Antas P, Li VS. Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. Am J Physiol Cell Physiol. 2015;309(8):C511\u201321.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"5203_CR36","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1080\/21655979.2022.2073115","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Li S, Nian S, Xu W, Liang F. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc. Bioengineered. 2022;13(5):12115\u201326.","journal-title":"Bioengineered"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05203-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05203-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05203-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:03:52Z","timestamp":1785852232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05203-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5203"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05203-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All subjects were approved by The First Affiliated Hospital of Jinan University (No.2022-JN261). All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of The First Affiliated Hospital of Jinan University (No.2022-JN386).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The maximum tumour size\/burden permitted by the Ethics Committee is a volume of 2000 mm\n                      3\n                      . No mouse in this study has violated this standard and did not exceed the maximum tumour size\/burden.","order":2,"name":"Ethics","label":"Tumor size in experimental animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each subject.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1111"}}